These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20486197)

  • 1. Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality.
    Onguru P; Dagdas S; Bodur H; Yilmaz M; Akinci E; Eren S; Ozet G
    J Clin Lab Anal; 2010; 24(3):163-6. PubMed ID: 20486197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
    Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H
    Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the associations between endothelial dysfunction, inflammation and coagulation in Crimean-Congo hemorrhagic fever patients.
    Doğan HO; Büyüktuna SA; Kapancik S; Bakir S
    Arch Virol; 2018 Mar; 163(3):609-616. PubMed ID: 29159591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever.
    Ekiz F; Gürbüz Y; Basar Ö; Aytekin G; Ekiz Ö; Sentürk ÇŞ; Aktas B; Yılmaz B; Altınbaş A; Çoban Ş; Şencan İ
    Clin Appl Thromb Hemost; 2013; 19(4):441-4. PubMed ID: 22431857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: Viral load.
    Hasanoglu I; Guner R; Carhan A; Kocak Tufan Z; Yagci-Caglayik D; Guven T; Yilmaz GR; Tasyaran MA
    J Clin Virol; 2016 Feb; 75():42-6. PubMed ID: 26780111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality.
    Cevik MA; Erbay A; Bodur H; Gülderen E; Baştuğ A; Kubar A; Akinci E
    Int J Infect Dis; 2008 Jul; 12(4):374-9. PubMed ID: 18063402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Role of Blood Urea Nitrogen and C-Reactive Protein and Their Ratios to Albumin in Predicting Mortality in Crimean-Congo Hemorrhagic Fever].
    Karaşahin Ö; İnan Sarıkaya R
    Mikrobiyol Bul; 2023 Jul; 57(3):419-431. PubMed ID: 37462305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of D-dimer, natural anticoagulants and routine coagulation parameters in acute pancreatitis.
    Badhal SS; Sharma S; Saraya A; Mukhopadhyay AK
    Trop Gastroenterol; 2012; 33(3):193-9. PubMed ID: 23600050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.
    Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP
    Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism.
    Sun W; Ren H; Gao CT; Ma WD; Luo L; Liu Y; Jin P; Hao JH
    Am J Clin Oncol; 2015 Dec; 38(6):550-6. PubMed ID: 24401666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bleeding Risk Score in Patients with Crimean-Congo Hemorrhagic Fever].
    Karaşahin Ö; Karaşahin EF
    Mikrobiyol Bul; 2021 Jul; 55(3):327-341. PubMed ID: 34416800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].
    Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever.
    Tasdelen Fisgin N; Tanyel E; Doganci L; Tulek N
    Trop Doct; 2009 Jul; 39(3):158-60. PubMed ID: 19535753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical pathology of Crimean-Congo hemorrhagic fever.
    Swanepoel R; Gill DE; Shepherd AJ; Leman PA; Mynhardt JH; Harvey S
    Rev Infect Dis; 1989; 11 Suppl 4():S794-800. PubMed ID: 2749111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of platelet distribution width in patients with Crimean-Congo hemorrhagic fever.
    Yilmaz H; Yilmaz G; Menteşe A; Kostakoğlu U; Karahan SC; Köksal İ
    J Med Virol; 2016 Nov; 88(11):1862-6. PubMed ID: 27089100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
    Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
    Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of freezing plasma at -20°C for 2 weeks on prothrombin time, activated partial thromboplastin time, dilute Russell viper venom time, activated protein C resistance, and D-dimer levels.
    Foshat M; Bates S; Russo W; Huerta A; Albright K; Giddings K; Indrikovs A; Qian YW
    Clin Appl Thromb Hemost; 2015 Jan; 21(1):41-7. PubMed ID: 24842886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic and prognostic significance of SCUBE1 levels in Crimean-Congo hemorrhagic fever.
    Menteşe A; Yilmaz G; Sümer A; Arslan M; Karahan SC; Köksal I
    Int J Infect Dis; 2013 Nov; 17(11):e1042-5. PubMed ID: 23632301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Mortality in Crimean-Congo Hemorrhagic Fever Patients Admitted at a Tertiary Care Hospital in Pakistan over the Last 10 Years: A Case-Control Study.
    Sethi SM; Zahid S; Nasir N
    Am J Trop Med Hyg; 2024 Aug; 111(2):416-420. PubMed ID: 38889713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemostatic reference intervals in pregnancy.
    Szecsi PB; Jørgensen M; Klajnbard A; Andersen MR; Colov NP; Stender S
    Thromb Haemost; 2010 Apr; 103(4):718-27. PubMed ID: 20174768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.